|
|
Volumn 56, Issue 4, 1997, Pages 245-250
|
|
Phase II clinical trial of a vas deferens injectable contraceptive for the male
a,c
|
|
Author keywords
Injectable male contraceptive; Pregnancy protection; Styrene maleic anhydride
|
|
Indexed keywords
DIMETHYL SULFOXIDE;
MALE CONTRACEPTIVE AGENT;
RISUG;
STYRENE MALEIC ANHYDRIDE COPOLYMER;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
AZOOSPERMIA;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG SAFETY;
HORMONAL CONTRACEPTION;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
HUMAN TISSUE;
MALE;
NORMAL HUMAN;
PHASE 2 CLINICAL TRIAL;
PREGNANCY RATE;
SPERMATOZOON MOTILITY;
VAS DEFERENS;
ASIA;
BIOLOGY;
CLINICAL RESEARCH;
CONTRACEPTION;
CONTRACEPTION RESEARCH;
CONTRACEPTIVE AGENTS;
CONTRACEPTIVE AGENTS, MALE;
CONTRACEPTIVE METHODS;
DEVELOPING COUNTRIES;
FAMILY PLANNING;
GENITALIA;
GENITALIA, MALE;
INDIA;
INJECTABLES;
MALE CONTRACEPTION;
PHYSIOLOGY;
REPRODUCTION;
RESEARCH METHODOLOGY;
RESEARCH REPORT;
SOUTHERN ASIA;
SPERMATOGENESIS;
UROGENITAL SYSTEM;
VAS DEFERENS;
ADULT;
CONTRACEPTIVE AGENTS, MALE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS;
MALE;
MALEIC ANHYDRIDES;
OLIGOSPERMIA;
POLYSTYRENES;
SPERMATOZOA;
VAS DEFERENS;
|
|
EID: 0030658899
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/S0010-7824(97)00142-X Document Type: Article |
|
Times cited : (83)
|
|
References (8)
|
